Royal Bank of Canada
CSBR icon

Royal Bank of Canada’s Champions Oncology CSBR Stock Holding History

Royal Bank of Canada’s Portfolio CSBR Stock Details CSBR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-6,614
Closed -$43K – 7235
2025
Q3 		$43K Sell
6,614
-1,114
-14% -$7.85K ﹤0.01% 5889
2025
Q2 		$57K Buy
7,728
+102
+1% +$720 ﹤0.01% 5865
2025
Q1 		$66K Buy
+7,626
New +$77.3K ﹤0.01% 5439
2024
Q3 		– Sell
-133
Closed -$1K – 6942
2024
Q2 		$1K Buy
133
+69
+108% +$336 ﹤0.01% 6800
2024
Q1 		$0 Sell
64
-156
-71% -$913 ﹤0.01% 7086
2023
Q4 		$1K Buy
220
+193
+715% +$1.08K ﹤0.01% 6906
2023
Q3 		$0 Sell
27
-199
-88% -$1.26K ﹤0.01% 7151
2023
Q2 		$1K Sell
226
-1,440
-86% -$7.43K ﹤0.01% 6981
2023
Q1 		$7K Buy
1,666
+1,518
+1,026% +$6.49K ﹤0.01% 6447
2022
Q4 		$0 Sell
148
-30
-17% -$196 ﹤0.01% 7291
2022
Q3 		$2K Buy
178
+78
+78% +$652 ﹤0.01% 6998
2022
Q2 		$1K Hold
100
– – ﹤0.01% 7102
2022
Q1 		$1K Hold
100
– – ﹤0.01% 7584
2021
Q4 		$1K Sell
100
-25
-20% -$230 ﹤0.01% 7490
2021
Q3 		$1K Sell
125
-1,229
-91% -$12.5K ﹤0.01% 7463
2021
Q2 		$14K Buy
1,354
+598
+79% +$6.06K ﹤0.01% 6731
2021
Q1 		$8K Buy
756
+396
+110% +$4.6K ﹤0.01% 6887
2020
Q4 		$4K Buy
360
+260
+260% +$2.68K ﹤0.01% 6724
2020
Q3 		$1K Hold
100
– – ﹤0.01% 6406
2020
Q2 		$1K Sell
100
-8
-7% -$68 ﹤0.01% 6400
2020
Q1 		$1K Sell
108
-63
-37% -$440 ﹤0.01% 6412
2019
Q4 		$2K Sell
171
-5
-3% -$31 ﹤0.01% 6546
2019
Q3 		$1K Buy
176
+76
+76% +$493 ﹤0.01% 6421
2019
Q2 		$1K Buy
+100
New +$877 ﹤0.01% 6683
2018
Q4 		– Sell
-14
Closed – – 6806
2018
Q3 		$0 Buy
+14
New +$125 ﹤0.01% 6753

Other funds holding CSBR

BMC
Battery Management Corp Boston, Massachusetts $426M AUM 21.5% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MBAM
Mink Brook Asset Management West Palm Beach, Florida $179M AUM 37.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Royal Bank of Canada's CSBR Position: Q4 2025 in Review

Royal Bank of Canada sold out of Champions Oncology (CSBR) in Q4 2025, closing a stake of 6,614 shares — an estimated $43K sold.

Royal Bank of Canada first reported a position in CSBR in Q3 2018 and held it in 25 quarters. The position peaked at $66K in Q1 2025. 27 funds tracked by Wall St. Rank hold CSBR as of Q4 2025.

  • Royal Bank of Canada reported no remaining Champions Oncology position as of Q4 2025 after selling out during the quarter.
  • Royal Bank of Canada sold 6,614 Champions Oncology shares in Q4 2025, an estimated $43K.
  • Royal Bank of Canada first reported a position in Champions Oncology in Q3 2018 and held it in 25 quarters.
  • Royal Bank of Canada's Champions Oncology position peaked at $66K in Q1 2025.
  • 27 funds tracked by Wall St. Rank held Champions Oncology as of Q4 2025.

Based on Royal Bank of Canada's 13F filing for Q4 2025, filed 17 Feb 2026.